Cox Communications, Inc. v. Sony Music Entertainment - Contributory Copyright Infringement

The Supreme Court ruled that Cox Communications could not invoke the DMCA safe-harbor defense based on its efforts to reduce infringement because an earlier Fourth Circuit decision had foreclosed that defense for the relevant period. The Court clarified the standards for secondary copyright liability, emphasizing that a service provider is only contributorily liable if it intended the service be used for infringement, either through active inducement or because the service is tailored to infringement with no substantial noninfringing uses.

Texas AG Launches Medicaid Fraud Investigations Using DOGE Data

Texas Attorney General Ken Paxton's Healthcare Program Enforcement Division has launched investigations into dozens of Medicaid providers using federal HHS Medicaid claims data released by the Department of Government Efficiency (DOGE). The investigations target home health providers, occupational therapy providers, and entities that potentially committed fraud related to COVID-19 treatments. The AG's office will utilize Civil Investigative Demands (CIDs) and other investigative tools as it pursues enforcement actions.

Rakuten Symphony NGDU managing multiple radio carriers O-RAN 847 units

USPTO granted Patent US12598046B2 to Rakuten Symphony, Inc. covering a Near-Real Time Distributed Unit (NGDU) designed to manage multiple radio carriers in Open Radio Access Network (O-RAN) architectures. The patent describes technology for mapping CPRI ports connecting radio units to distributed units, enabling efficient communication management across O-RAN networks.

Mutable Digital Asset Storage Units for Decentralised Peer-to-Peer Verification

The USPTO granted Patent US12598058B2 to British Telecommunications Public Limited Company covering methods for managing mutable digital asset storage units in a decentralised peer-to-peer storage network using cryptographic verification. The patent includes 19 claims relating to selection criteria rules, cryptographic processing functions, and version management of storage units across peer computing systems.

Similarity Calculation System with Homomorphic Encryption

USPTO granted patent US12598057B2 to NEC Corporation on April 7, 2026, covering a similarity calculation system using homomorphic encryption. The system enables secure distance calculations between vectors where one vector remains encrypted on a similarity calculation apparatus while the other is input from a terminal. The invention uses weighted distance tables and additive homomorphic encryption to compute ciphertext sums of element distances.

Benzalkonium Chloride for Treating COVID-19 and Conjunctivitis

USPTO granted patent US12594251B2 to Bausch + Lomb Ireland Limited on April 7, 2026, covering methods of treating COVID-19 (including ocular manifestations) and conjunctivitis using benzalkonium chloride, as well as methods for reducing COVID-19 transmission using the compound. The patent, with inventors Patrick McCormick and Kimberly Millard, contains 40 claims and is classified under CPC codes A61K 31/14, A61P 27/02, and A61P 31/14.

Small molecule compounds for treating lung epithelial and vascular endothelial cell injury

USPTO granted patent US12594282B2 to Guangzhou Cellprotek Pharmaceutical Co., Ltd. on April 7, 2026. The patent covers the use of 5α-androst-3β,5,6β-triol and analogues for treating pulmonary diseases mediated by lung epithelial cell injury and/or vascular endothelial cell injury. The compounds inhibit PFKFB3 expression and reduce vascular endothelial and alveolar epithelial cell injury.

SCYNEXIS patent for triterpenoid antifungals treating Pneumocystis pneumonia

The USPTO issued patent US12594266B2 to SCYNEXIS, INC. on April 7, 2026, covering eufumafungin derivative triterpenoid antifungal compounds and their use in treating or preventing Pneumocystis pneumonia (PCP). The patent includes 16 claims encompassing the compound structures, pharmaceutical compositions, and methods of treatment.

Methods for treating inflammatory skin conditions (minocycline)

USPTO granted Journey Medical Corporation Patent US12594252B2 covering methods of treating inflammatory skin conditions using reduced-dose minocycline compositions. The patent, with 39 claims, names six inventors including Swati Kulkarni and Rajeev Singh Raghuvanshi. The invention relates to administering a pharmaceutical composition comprising a reduced dose of minocycline to achieve effective plasma or interstitial fluid concentrations for treating inflammatory skin conditions.

Patent US12594280B2: Antiviral Compositions for Influenza Treatment

USPTO granted Patent US12594280B2 to Universite Claude Bernard Lyon 1 covering antiviral pharmaceutical compositions containing Etilefrine and Diltiazem for preventing and treating influenza virus infections. The patent includes 10 claims and covers the use of these compounds in veterinary and pharmaceutical compositions.